GoldenEye++: A Closer Look into the Black Box
暂无分享,去创建一个
Panagiotis Papapetrou | Jing Zhao | Kai Puolamäki | Isak Karlsson | Henrik Boström | Lars Asker | Andreas Henelius
[1] L. Härmark,et al. Pharmacovigilance: methods, recent developments and future perspectives , 2008, European Journal of Clinical Pharmacology.
[2] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[3] A. Egberts,et al. Detecting drug–drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs , 2000, European Journal of Clinical Pharmacology.
[4] Gerald A. Faich,et al. Factors Affecting Physician Reporting of Adverse Drug Reactions , 1986 .
[5] Bruce M Psaty,et al. Detection, verification, and quantification of adverse drug reactions , 2004, BMJ : British Medical Journal.
[6] Hercules Dalianis,et al. Stockholm EPR Corpus : A Clinical Database Used to Improve Health Care , 2012 .
[7] Panagiotis Papapetrou,et al. A peek into the black box: exploring classifiers by randomization , 2014, Data Mining and Knowledge Discovery.
[8] G. Niklas Norén,et al. Opportunities and challenges of adverse drug reaction surveillance in electronic patient records , 2010 .
[9] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[10] Nitesh V. Chawla,et al. Data Mining for Imbalanced Datasets: An Overview , 2005, The Data Mining and Knowledge Discovery Handbook.
[11] Leo Breiman,et al. Random Forests , 2001, Machine Learning.